Application of the Ranger® Technology (Stratophase) to T-Cell Expansion in Stirred Tank Reactors
Lead Participant:
CELL THERAPY CATAPULT LIMITED
Abstract
Awaiting Public Project Summary
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| CELL THERAPY CATAPULT LIMITED | £263,900 | £ 263,900 |
Participant |
||
| THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST |
People |
ORCID iD |
| Emma Kinsey (Project Manager) |